Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $10.44, but opened at $11.00. Veradigm shares last traded at $10.50, with a volume of 30,243 shares changing hands.
Analyst Upgrades and Downgrades
Separately, StockNews.com initiated coverage on shares of Veradigm in a research report on Sunday, November 17th. They set a “hold” rating on the stock. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $11.75.
Get Our Latest Stock Analysis on MDRX
Veradigm Price Performance
Hedge Funds Weigh In On Veradigm
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Roth IRA Calculator: Calculate Your Potential Returns
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.